Faster lymphoma diagnosis using flow cytometry on lymph node samples
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a faster way to check lymph node samples for lymphoma, giving results in hours instead of days. If you're already having a lymph node biopsy, this could mean a quicker diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are being checked for cancer because you have swollen lymph nodes.
- Your doctor thinks lymphoma (a type of blood cancer) might be a possibility.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a faster way to get a tissue sample from lung cancer or lymphoma tumors that are near the esophagus or stomach. The goal is to start your treatment sooner by using a special ultrasound scope to do a biopsy right away.
This study uses special lab testing (“omics”) on people with certain fast-growing B-cell lymphomas to find results that can help with diagnosis and predicting outcomes. It may help by improving how clinicians identify the lymphoma type and forecast how it may behave.
This trial looks at whether PET/CT scans can better predict outcomes in people with fast-growing lymphoma. If you are newly diagnosed and receiving standard treatment, the study may help refine how response is evaluated.
This study looks at specific immune cells (T cells) in people who have a rare condition called Hemophagocytic Lymphohistiocytosis (HLH) together with an aggressive lymphoma. It aims to better understand how these cells behave, which may lead to improved diagnosis or treatment.
This trial tests whether a shorter course of bendamustine and rituximab (chemotherapy plus antibody treatment) can work just as well for slow-growing non-Hodgkin lymphoma. It uses a special blood test to monitor cancer levels and decide if treatment can be safely reduced.
This study checks whether measuring a blood test called “circulating tumor DNA” (ctDNA) helps monitor childhood lymphoma during treatment. It’s meant to see if ctDNA tracking can provide useful information alongside standard exams.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.